A Full Plate for the New U.S. Trade Czar


By Rodney Emery

The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

They aren't necessarily the trade issues that grab the biggest headlines, like tough new negotiations with major rivals. In fact, one of the most important tasks for Tai is simply enforcement of existing deals with close U.S. trading partners.

Well-thought-out, well-enforced trade deals benefit all Americans, ensuring lower prices for consumers, higher earnings for businesses, and protections for workers and the environment. As the president's main advisor and negotiator on trade, Tai is charged with making sure these agreements work like they're supposed to. Her success will be crucial to our country's post-pandemic economic recovery.

For starters, America's neighbors to the North and South may be undermining the United States-Mexico-Canada Agreement -- the USMCA -- which entered into force just last year.

Now, though, legislation advancing in Mexico threatens to close off foreign investment in the country's energy sector, which would violate its USMCA commitments, while U.S. dairy farmers are concerned that Canada has failed to open its dairy market as promised.

Farther afield, U.S. companies operating in Japan are concerned that its government discriminates against American car and drug makers.

Auto manufacturers say that overly strict safety testing requirements keep American firms from expanding into the Japanese market. Pharmaceutical companies, meanwhile, face opaque decision-making and last-minute policy changes that discourage them from introducing new medicines in Japan.

Virtually all U.S. sectors are affected by international trade, and that includes the 2.5 million American workers supported by our film and television industry. In Indonesia, the government requires movie theaters to commit nearly two-thirds of their screens to domestically produced films. It even bans dubbing foreign films. These restrictions limit Hollywood studios from licensing and marketing movies in this fast-growing market of 270 million citizens.

At the same time, trade enforcement is a challenge in U.S. relations with India. In particular, weak copyright and patent enforcement discourages companies in fields from entertainment to biopharmaceuticals from expansion in the world's largest democracy.

Of course, the chief trade negotiator handles not just bilateral relationships with foreign governments but also diplomacy at the World Trade Organization, the 164-member body that regulates so much international trade.

The Indian and South African governments recently petitioned the World Trade Organization to waive intellectual property protections on vaccines and treatments for Covid-19. Their wish to act is understandable, as we grapple with a once-in-a-century global health crisis. But besides the fact that gutting patent rights wouldn't speed vaccine distribution, the proposal would have a dire long-term impact on global intellectual property rights. It would undermine every U.S. firm that relies on these rights when investing in drug development.

By all accounts, Tai, who served for seven years in the Office of the U.S. Trade Representative, is a skilled negotiator. And the United States has strong bilateral relationships for her to build on as she faces off with foreign counterparts.

But the stakes are high, and time is short. Strong trade enforcement means robust trade, which translates into more high-paying U.S. jobs. Addressing trade tensions with allies -- like Canada, Mexico, Japan, India, Indonesia, and Brazil -- will jump-start the U.S. economy as we recover from Covid-19. We're counting on Tai to deliver.

Rodney Emery is a principal at Squire Patton Boggs and former director of congressional affairs for the International Trade Administration (ITA) within the U.S. Department of Commerce.

More Resources


11/20/2024
What Donald Trump's Revenge Agenda Is Hiding
Look past the flashy and controversial Cabinet nominees to find that Project 2025 is already being implemented

more info


11/20/2024
Make Education Great Again!
Imagine these words as the first speech delivered by the incoming Secretary of Education.Today, I am here to deliver bitter medicine: American education has failed. Teachers and parents, administrato

more info


11/20/2024
Time-Honored Tradition of Blaming the Left for Dem Defeats
This argument is particularly unconvincing this time around. And it doesn't offer a realistic prescription for future success.

more info


11/20/2024
Dems Are Going To Get Younger and More Radical


more info


11/20/2024
The Blurred Line Between X and the Trump Administration
Forget the ridiculous

more info


11/20/2024
DOGE Is a Great Idea. Trump Should Make It Permanent
DOGE represents a harbinger of deregulation for an incoming Trump administration, especially with Dogecoin enthusiast Elon Musk and Vivek Ramaswamy at the helm.

more info


11/20/2024
The DOGE Plan To Reform Government
Following the Supreme Court's guidance, we'll reverse a decadeslong executive power grab.

more info


11/20/2024
Could Trump Actually Get Rid of the Department of Education?
Getting rid of the agency would cause a lot of harm and wouldn't really change school curriculum.

more info


11/20/2024
How Dems Are Losing Tomorrow's Elections Today
America is outgrowing the Democratic Party.

more info


11/20/2024
Can a Fractured Democratic Party Learn the Lessons of 2024?
After a bruising campaign season and a humiliating defeat at the polls, this week saw Dems' internal conflicts spilling out into public view. Party insiders are now engaged in tit-for-tat Twitter battles that do nothing to offer the party a roadmap back to political contender status. Instead, they confirm normies' worst caricatures of Democratic dysfunction.

more info


11/20/2024
Pennsylvania Voters to Sen. Casey: 'It's Over, Bob'
Columnist David Marcus talks to voters in Bucks County and finds Democrats and Republicans agree that Sen. Bob Casey's refusal to concede is a bad look.

more info


11/20/2024
NC Republicans' Shameless New Power Grab
North Carolina voters spoke loud and clear two weeks ago when they elected Democrats to some of the most prominent statewide offices.

more info


11/20/2024
Trump Can and Should Fire Jerome Powell
Legacy media have been obsessing over whether President-elect Donald Trump can remove Jerome Powell, chairman of the Federal Reserve (the Fed). Jerome Powell recently came out and stated he would serve out his term - which ends in 2026. Further, Chairman Powell claims any attempt by President Trump to remove him is not "permitted under the law." Unfortunately for Chairman Powell, President-elect Trump can remove him - and he should - to make the federal bureaucracy respond to democratic pressures once again.

more info


11/20/2024
SecDef Austin: Women in Military Make U.S. Stronger
Austin in an exclusive interview with NBC News called women in the military a strong asset. Trump's choice for Secretary of Defense has cast doubt on women in combat roles.

more info


11/20/2024
Drone, Missile Defense Top Priorities for Next Defense Secretary
Pete Hegseth faces critical challenges in addressing U.S. vulnerabilities to advanced missile and drone threats as global tensions rise.

more info



Custom Search

More Politics Articles:

Related Articles

Americans Can't Afford Insurance — and Obamacare is to Blame


The number of uninsured Americans rose in 2018 for the first time since the Affordable Care Act passed in 2010, according to the Census Bureau.

ICER Discriminates Against People with Rare Diseases


FDA officials approved a record number of rare disease treatments last year. One groundbreaking medicine treats an inherited bone condition that causes intense pain and immobility. Another treats Fabry disease, a genetic condition that can lead to kidney failure or stroke.

Minor Legislation with Massive Implications


U.S. Senator Ron Johnson (R-WI) is promoting the "Prevent Government Shutdown Act of 2019." The goal of the act is to prevent disruptive government shutdowns.

When Humans Don't Procreate


The "hook" of the story intrigued me: "This hasn't happened in all of modern history..." An email from "The Crux" last month blared, "Global population growth to virtually stop by 2100."

Beware of Bills in Sheep's Clothing


There is a bipartisan tradition of naming bills such that no reasonable person would oppose them. For instance, changes to our tax system came with the passage of the Tax Cuts and Jobs Act. Who's against jobs? And how could anyone have voted against the Patient Protection and Affordable Care Act (i.e., "Obamacare")?

Offshore Bans Hurt Working Class Americans


Congressional Democrats just betrayed America's working class.

If You Like Your Health Plan, You Can't Keep It Under a Public Option


Nearly two in three Americans support the creation of a government-sponsored health plan to compete against plans offered by private insurers, according to the most recent survey data from the Kaiser Family Foundation.

Don't Legalize Discrimination Against People With Disabilities


Imagine if the federal government treated disabled Americans as second-class citizens. It's an appalling thought. But it could happen soon -- if some special interest groups get their way.

It's Time to Turn the Prescription Drug Debate on its Head


Politicians typically blame drug companies for soaring pharmacy prices. But insurers, pharmacies, and other middlemen are the real driving force behind rising drug spending.

U.S. Carbon Emissions Are Actually Dropping


Increased natural gas consumption helped bring down U.S. greenhouse gas emissions in 2019, according to a recent report from the U.S. Energy Information Administration.

"Buy American" Executive Order Could Slow Delivery of a Coronavirus Cure


President Trump is considering a "Buy American" executive order requiring government agencies to purchase medicines and medical supplies domestically.

Don't Disrupt the Supply Chain in the Midst of a Pandemic


The Trump administration fears America has lost its ability to mass-produce the medicines and medical supplies needed to fight the coronavirus and other, future pandemics. So it's considering an executive order to bring drug and medical-supply manufacturing back to the United States.

Intellectual Property Makes Sure Drug Makers Deliver


House Democrats Peter DeFazio, Rosa DeLauro, Lloyd Doggett, and Jan Schakowsky want to nullify intellectual property rights on any experimental treatments for COVID-19. They believe their proposals will prevent "price gouging and profiteering" without harming innovation.

Move These Projects Forward and Get America Back to Work


With more than 40 million Americans out of a job due to the coronavirus pandemic, states are scrambling to help the unemployed and laying plans to reopen the economy.

COVID-19 Cost-Effectiveness Research Deepens Racial Disparities


A newly released study by the Institute for Clinical and Economic Review (ICER), a Boston-based nonprofit, attempts to answer a weighty question: How much should it cost to treat the coronavirus?